Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Finished Goods: 2023-2024

  • Zhengye Biotechnology Holding's Finished Goods rose 17.75% to $2.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $2.4 million, marking a year-over-year increase of 17.75%. This contributed to the annual value of $2.5 million for FY2024, which is 17.40% up from last year.
  • Zhengye Biotechnology Holding's Finished Goods amounted to $2.4 million in Q4 2024, which was up 17.75% from $2.1 million recorded in Q4 2023.
  • In the past 5 years, Zhengye Biotechnology Holding's Finished Goods ranged from a high of $2.4 million in Q4 2024 and a low of $2.1 million during Q4 2023.
  • For the 2-year period, Zhengye Biotechnology Holding's Finished Goods averaged around $2.2 million, with its median value being $2.2 million (2023).
  • Data for Zhengye Biotechnology Holding's Finished Goods shows a peak YoY increased of 17.75% (in 2024) over the last 5 years.
  • Zhengye Biotechnology Holding's Finished Goods (Quarterly) stood at $2.1 million in 2023, then climbed by 17.75% to $2.4 million in 2024.